Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Apogee Therapeutics Inc | 8,493,321 | 8,493,321 | 0 | $641.08M | $714.88M | 26.68% | +$73.81M |
| Erasca, Inc.(ERAS) | 17,857,083 | 16,382,812 | -1,474,271 | $66.43M | $265.07M | 9.89% | +$198.65M |
| Oruka Therapeutics, Inc.(ORKA) | 4,148,428 | 4,148,428 | 0 | $125.74M | $203.48M | 7.60% | +$77.74M |
| Spyre Therapeutics, Inc.(SYRE) | 3,685,448 | 3,685,448 | 0 | $120.74M | $185.89M | 6.94% | +$65.16M |
| Kalvista Pharmaceuticals Inc | 6,728,985 | 6,474,485 | -254,500 | $108.67M | $130.33M | 4.86% | +$21.66M |
| Dianthus Therapeutics, Inc.(DNTH) | 1,000,000 | 1,180,000 | +180,000 | $41.21M | $99.03M | 3.70% | +$57.82M |
| Damora Therapeutics, Inc.(DMRA) | 0 | 3,603,595 | +3,603,595 | $0 | $93.33M | 3.48% | +$93.33M |
| Ocular Therapeutix, Inc.(OCUL) | 7,315,547 | 10,346,926 | +3,031,379 | $88.81M | $87.64M | 3.27% | -$1.17M |
| Cogent Biosciences, Inc.(COGT) | 2,000,000 | 2,000,000 | 0 | $71.04M | $76.98M | 2.87% | +$5.94M |
| Viridian Therapeutics, Inc.(VRDN) | 3,882,709 | 3,882,709 | 0 | $120.83M | $75.95M | 2.83% | -$44.88M |
| Savara Inc.(SVRA) | 13,740,375 | 13,740,375 | 0 | $82.85M | $75.02M | 2.80% | -$7.83M |
| Enliven Therapeutics Inc | 3,226,331 | 1,726,331 | -1,500,000 | $49.69M | $67.67M | 2.53% | +$17.99M |
| ORIC Pharmaceuticals, Inc.(ORIC) | 5,676,230 | 4,319,765 | -1,356,465 | $46.43M | $54.73M | 2.04% | +$8.30M |
| Vor Biopharma Inc.(VOR) | 1,943,766 | 3,041,719 | +1,097,953 | $25.42M | $54.26M | 2.03% | +$28.84M |
| Maze Therapeutics, Inc.(MAZE) | 1,548,569 | 1,602,034 | +53,465 | $64.16M | $47.82M | 1.78% | -$16.34M |
| CytomX Therapeutics, Inc.(CTMX) | 15,561,500 | 9,982,124 | -5,579,376 | $66.29M | $46.92M | 1.75% | -$19.38M |
| Jade Biosciences Inc | 3,220,364 | 3,220,364 | 0 | $49.69M | $45.25M | 1.69% | -$4.44M |
| Dyne Therapeutics, Inc.(DYN) | 2,173,913 | 2,173,913 | 0 | $42.52M | $39.41M | 1.47% | -$3.11M |
| Crescent Biopharma, Inc.(CBIO) | 2,133,576 | 2,133,576 | 0 | $25.30M | $39.19M | 1.46% | +$13.89M |
| Zura Bio LimitedCL A(ZURA) | 5,345,115 | 6,434,990 | +1,089,875 | $28.01M | $38.29M | 1.43% | +$10.28M |
| Relmada Therapeutics, Inc.(RLMD) | 0 | 4,843,380 | +4,843,380 | $0 | $33.71M | 1.26% | +$33.71M |
| Engene Holdings Inc COM | 4,771,414 | 4,771,414 | 0 | $43.09M | $32.49M | 1.21% | -$10.59M |
| Tenax Therapeutics, Inc.(TENX) | 0 | 1,675,262 | +1,675,262 | $0 | $26.79M | 1.00% | +$26.79M |
| Adlai Nortye Group Ltd.ADS(ANL) | 0 | 3,212,731 | +3,212,731 | $0 | $22.23M | 0.83% | +$22.23M |
| Century Therapeutics, Inc.(IPSC) | 0 | 8,695,652 | +8,695,652 | $0 | $19.65M | 0.73% | +$19.65M |
| Cullinan Therapeutics, Inc.(CGEM) | 1,379,965 | 1,379,965 | 0 | $14.28M | $19.61M | 0.73% | +$5.33M |
| Cybin D/B/A Helus Pharma(HELP) | 3,840,250 | 3,851,654 | +11,404 | $31.41M | $18.49M | 0.69% | -$12.93M |
| Surrozen, Inc.(SRZN) | 632,931 | 632,931 | 0 | $14.30M | $18.44M | 0.69% | +$4.13M |
| Septerna, Inc.(SEPN) | 610,808 | 506,056 | -104,752 | $17.03M | $12.16M | 0.45% | -$4.87M |
| Korro Bio, Inc.(KRRO) | 0 | 1,009,500 | +1,009,500 | $0 | $11.43M | 0.43% | +$11.43M |
| Alto Neuroscience, Inc.(ANRO) | 0 | 500,000 | +500,000 | $0 | $11.24M | 0.42% | +$11.24M |
| Artiva Biotherapeutics, Inc.(ARTV) | 1,609,569 | 1,609,569 | 0 | $6.91M | $10.37M | 0.39% | +$3.46M |
| X4 Pharmaceuticals, Inc.(XFOR) | 0 | 330,525 | +330,525 | $0 | $1.37M | 0.05% | +$1.37M |
| CASI Pharmaceuticals, Inc.(CASIF) | 987,259 | 0 | -987,259 | $839.2K | $0 | — | -$839.2K |
| Upstream Bio, Inc.(UPB) | 1,169,298 | 0 | -1,169,298 | $31.75M | $0 | — | -$31.75M |